(1) The National Health Service (Pharmaceutical Services) (Wales) Regulations 2020 are amended as follows.
(2) In regulation 2(1) (Interpretation)—
(a) in the definition of “Electronic prescription form”, in paragraph (b), for “ETP” substitute “electronic prescription” ,
(b) omit the definition of “ETP service”,
(c) in the appropriate place, insert—
“ Prescription only medicine ” (“ meddyginiaeth a roddir ar bresgripsiwn yn unig ”) means a medicine referred to in regulation 5(3) (classification of medicinal products) of the Human Medicines Regulations 2012;
(d) in the definition of “Repeatable prescription”, in paragraph (a)(ii), for “ETP” substitute “electronic prescription” .
(3) In Schedule 5—
(a) in Part 2, in the heading to paragraph 5A before “listed”, in each place it occurs, insert “ophthalmic” ,
(b) in Part 2, in paragraph 5A—
(i) for “a listed”, in each place it occurs, substitute “an ophthalmic listed” ;
(ii) in sub paragraph (3)(a), for “paragraph” substitute “sub-paragraph” ; and
(iii) in sub-paragraph (5), for “paragraph” substitute “sub-paragraph” ;
(c) in Part 2, in paragraph 9 , in sub-paragraph (8C)(b), omit “directly”;
(d) in Part 2, for paragraph 20(4) substitute—
(4) The NHS pharmacist must, in appropriate cases, keep and maintain a record of any advice given and any interventions or referrals made (in particular of clinically significant interventions) under this paragraph.
(e) in Part 3, in paragraph 23(6B) , for “paragraph” substitute “sub-paragraph” .